PROM1 and hepatocellular carcinoma: Sulfasalazine can effectively inhibit the system Xc‐ activity of CD133‐positive hepatoma cells, weaken the ROS defence system and enhance the proliferation inhibition activity of cisplatin and DOX in CD133‐positive hepatoma cells.75